Sulphonylurea responsive monogenic diabetes in an Insulin treated 8 - year old child in West Africa; of more than academic interest and one of many?
Abstract
Abstract: We describe the case and identification of monogenic diabetes mellitus in a ogolese girl at the age of eight years, previously treated as Type 1 Diabetes following diagnosis at the age of two months. She has since been transitioned from insulin to oral sulphonylurea therapy, with improved glycaemic control and greater therapeutic security. We believe many more such cases must exist in Africa amongst those with a history of neonatal diabetes. Free genomic testing is available (see below) in suitable cases. The case highlights the value of personalized medicine and international cooperation.
Key Words: Neonatal Diabetes Sulphonylurea responsive monogenic diabetes
Published
Issue
Section
License
This is an open-access journal, and articles are distributed under the terms of the Creative Commons Attribution 4.0 License, which allows others to remix, transform, and build upon the work even, commercially, as long as appropriate credit is given to the author, and the new creations are licensed under identical terms